Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.52 % |
3 Month Return | -22.31 % |
1 Year Return | -19.6 % |
Market Stats | |
Previous Close | ₹38.59 |
Open | ₹38.00 |
Volume | 21.25K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹136.10Cr |
P/E Ratio | -8.85 |
PEG Ratio | -5.53 |
Market Cap | ₹136.10 Cr |
P/B Ratio | 2.58 |
EPS | -3.36 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹136.10 Cr | 136.23% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Pharmaids Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Limited has secured a ₹5 crore unsecured loan from Moki Financial Services to support working capital and repay existing liabilities. The loan, finalized on September 12, 2024, carries a 12% interest rate and a maximum tenure of 5 years. This funding aims to strengthen Pharmaids' financial position in the competitive pharmaceutical market.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 94.36% to 94.44% in Jun 2024 quarter
Best in 3 Years
In the last 3 years, Pharmaids Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 103.4%
Promoter Holding Down
Promoters have decreased holdings from 5.64% to 5.56% in Jun 2024 quarter
Price Dip
In the last 3 months, Pharmaids Pharma stock has moved down by -22.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 5.56% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 94.44% | 0.08 | |
Others | 0% | 0.00 |
Pharmaids Pharmaceuticals Ltd in the last 5 years
Lowest (-15.70x)
April 18, 2024
Today (-8.85x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (0.00x)
March 27, 2023
Pharmaids Pharmaceuticals Ltd’s net profit fell -828.57% since last year same period to ₹-1.30Cr in the Q1 2023-2024. On a quarterly growth basis, Pharmaids Pharmaceuticals Ltd has generated 78.9% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Pharmaids Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Pharmaids Pharmaceuticals Ltd (524572) share price today is ₹37.99
Pharmaids Pharmaceuticals Ltd is not listed on NSE
Pharmaids Pharmaceuticals Ltd is listed on BSE
PE Ratio of Pharmaids Pharmaceuticals Ltd is -8.85
PE ratio = Pharmaids Pharmaceuticals Ltd Market price per share / Pharmaids Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Pharmaids Pharmaceuticals Ltd(524572) is 21.25K.
Today’s market capitalisation of Pharmaids Pharmaceuticals Ltd(524572) is ₹136.1Cr.
Pharmaids Pharmaceuticals Ltd(524572 | Price |
---|---|
52 Week High | ₹79.23 |
52 Week Low | ₹35.36 |
Pharmaids Pharmaceuticals Ltd(524572) share price is ₹37.99. It is down -52.05% from its 52 Week High price of ₹79.23
Pharmaids Pharmaceuticals Ltd(524572) share price is ₹37.99. It is up 7.44% from its 52 Week Low price of ₹35.36
Pharmaids Pharmaceuticals Ltd(524572 | Returns |
---|---|
1 Day Returns | -0.6% |
1 Month Returns | -3.52% |
3 Month Returns | -22.31% |
1 Year Returns | -19.6% |